US SB417 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 7 2019 - 25% progression, died in committee
Action: 2019-02-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 7 2019 - 25% progression, died in committee
Action: 2019-02-07 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the Food and Drug Administration to amend its mission statement to take responsibility for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)
Title
Changing the Culture of the FDA Act
Sponsors
| Sen. Joe Manchin [D-WV] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-02-07 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Health
Prescription drugs
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Food and Drug Administration (FDA)
Health
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/417/all-info |
| Text | https://www.congress.gov/116/bills/s417/BILLS-116s417is.pdf |
